HARROW HEALTH INC's ticker is HROW and the CUSIP is 415858109. A total of 82 filers reported holding HARROW HEALTH INC in Q3 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,318,864 | -18.7% | 91,779 | +7.8% | 1.86% | +1.8% |
| Q2 2023 | $1,621,523 | -32.5% | 85,164 | -25.0% | 1.83% | -34.8% |
| Q1 2023 | $2,402,485 | +4.6% | 113,539 | -27.0% | 2.80% | +0.3% |
| Q4 2022 | $2,295,756 | +0.9% | 155,539 | -17.5% | 2.79% | +13.0% |
| Q3 2022 | $2,276,000 | +33.9% | 188,539 | -19.3% | 2.47% | +43.9% |
| Q2 2022 | $1,700,000 | -13.6% | 233,539 | -19.1% | 1.72% | +43.5% |
| Q1 2022 | $1,968,000 | -34.8% | 288,517 | -17.5% | 1.20% | -11.2% |
| Q4 2021 | $3,020,000 | -10.3% | 349,517 | -5.6% | 1.35% | +10.1% |
| Q3 2021 | $3,367,000 | -4.2% | 370,389 | -2.1% | 1.22% | +5.5% |
| Q2 2021 | $3,515,000 | +105.6% | 378,389 | +49.3% | 1.16% | +75.2% |
| Q1 2021 | $1,710,000 | +110.6% | 253,389 | +114.0% | 0.66% | +7.8% |
| Q4 2020 | $812,000 | – | 118,389 | – | 0.61% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 3,795,000 | $54,534,150 | 17.74% |
| Private Capital Management, LLC | 1,416,900 | $20,360,853 | 2.41% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 91,779 | $1,318,864 | 1.86% |
| Birchview Capital, LP | 150,000 | $2,155,500 | 1.84% |
| Diametric Capital, LP | 286,127 | $4,111,644 | 1.72% |
| Ophir Asset Management Pty Ltd | 492,179 | $7,072,612 | 1.67% |
| BRAIDWELL LP | 1,808,684 | $25,990,789 | 0.82% |
| Westside Investment Management, Inc. | 159,019 | $2,285,117 | 0.66% |
| INVICTUS PRIVATE WEALTH, LLC | 400,066 | $5,748,948 | 0.63% |
| Portolan Capital Management | 385,964 | $5,546,303 | 0.52% |